Behavioral effects of amphetamine in streptozotocin-treated rats

European Journal of Pharmacology

Volumn 581, Issue 1-2, 2008, Pages 105-112

  Sevak, Rajkumar J ^a   Koek, Wouter ^a,b   Daws, Lynette C ^a,b   Owens, William Anthony ^b   Galli, Aurelio ^c   France, Charles P ^a,b  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Conditioned place preference; Dopamine transporter; Locomotion; Streptozotocin

Indexed keywords

4 HYDROXYBUTYRIC ACID; AMPHETAMINE; COCAINE; GLUCOSE; HALOPERIDOL; KETAMINE; QUINPIROLE; RACLOPRIDE; SODIUM CHLORIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BODY WEIGHT; CONDITIONING; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG SENSITIVITY; GLUCOSE BLOOD LEVEL; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; CONDITIONING (PSYCHOLOGY); DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 38549164110     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.047     Document Type: Article

References (46)

1. Bardo M.T., and Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology 153 (2000) 31-43
2. Bell S.M., Stewart R.B., Thompson S.C., and Meisch R.A. Food deprivation increases cocaine-induced conditioned place preference and locomotor activity in rats. Psychopharmacology 131 (1997) 1-8
3. Borman N.M., and Cunningham C.L. Ethanol-induced conditioned place aversion in rats: effect of interstimulus interval. Pharmacol. Biochem. Behav. 59 (1998) 427-432
4. Campbell B.A., and Fibiger H.C. Potentiation of amphetamine-induced arousal by starvation. Nature 233 (1971) 424-425
5. Carr K.D. Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms. Physiol. Behav. 76 (2002) 353-364
6. Carroll M.E., France C.P., and Meisch R.A. Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation. J. Pharmacol. Exp. Ther. 217 (1981) 241-247
7. Carroll M.E., and Stotz D.C. Oral d-amphetamine and ketamine self-administration by rhesus monkeys: effects of food deprivation. J. Pharmacol. Exp. Ther. 227 (1983) 28-34
8. Carvelli L., Moron J.A., Kahlig K.M., Ferrer J.V., Sen N., Lechleiter J.D., Leeb-Lundberg L.M.F., Merrill G., Lafer E.M., Ballou L.M., Shippenberg T.S., Javitch J.A., Lin R.Z., and Galli A. PI 3-kinase regulation of dopamine uptake. J. Neurochem. 81 (2002) 859-869
9. Chester J.A., and Cunningham C.L. Modulation of corticosterone does not affect the acquisition or expression of ethanol-induced conditioned place preference in DBA/2J mice. Pharmacol. Biochem. Behav. 59 (1998) 67-75
10. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., Niznik H.B., and Levey A.I. The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15 (1995) 1714-1723
11. Figlewicz D.P., Brot M.D., McCall A.L., and Szot P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res. 736 (1996) 54-60
12. Figlewicz D.P., Evans S.B., Murphy J., Hoen M., and Baskin D.G. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res. 964 (2003) 107-115
13. Figlewicz D.P., Higgins M.S., Ng-Evans S.B., and Havel P.J. Leptin reverses sucrose-conditioned place preference in food-restricted rats. Physiol. Behav. 73 (2001) 229-234
14. Figlewicz D.P., Patterson T.A., Johnson L.B., Zavosh A., Israel P.A., and Szot P. Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats. Brain. Res. Bull. 46 (1998) 199-202
15. Figlewicz D.P., Szot P., Chavez M., Woods S.C., and Veith R.C. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res. 464 (1994) 331-334
16. Gaiardi M., Bartoletti M., Bacchi A., Gubellini C., and Babbini M. Increased sensitivity to the stimulus properties of morphine in food deprived rats. Pharmacol. Biochem. Behav. 26 (1987) 719-723
17. Galici R., Galli A., Jones D.J., Sanchez T.A., Saunders C., Frazer A., Gould G.G., Lin R.Z., and France C.P. Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in streptozotocin-treated rats. Neuroendocrinology 77 (2003) 132-140
18. Garcia B.G., Wei Y., Moron J.A., Lin R.Z., Javitch J.A., and Galli A. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol. Pharmacol. 68 (2005) 102-109
19. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
20. Han D.D., and Gu H.H. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 6 (2006) 6
21. Hemby S.E., Jones G.H., Justice Jr. B.J., and Neill D.B. Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine. Psychopharmacology 106 (1992) 330-336
22. Kamei J., and Ohsawa M. Effects of diabetes on methamphetamine-induced place preference in mice. Eur. J. Pharmacol. 318 (1996) 251-256
23. Kuczenski R., and Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J. Pharmacol. Exp. Ther. 296 (2001) 876-883
24. Kwok R.P., and Juorio A.V. Concentration of striatal tyramine and dopamine metabolism in STZ-treated rats and effect of insulin administration. Neuroendocrinology 43 (1986) 590-596
25. Lim D.K., Lee K.M., and Ho I.K. Changes in the central dopaminergic systems in the streptozotocin-induced diabetic rats. Arch. Pharm. Res. 17 (1994) 398-404
26. Marshall J.F. Further analysis of the resistance of the STZ-treated rat to d-amphetamine. Pharmacol. Biochem. Behav. 8 (1978) 281-286
27. Mayer L.A., and Parker L.A. Rewarding and aversive properties of IP and SC cocaine: assessment by place and taste conditioning. Psychopharmacology 112 (1993) 189-194
28. Nomikos G.G., and Spyraki C. Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology 94 (1988) 119-125
29. Owens W.A., Sevak R.J., Galici R., Chang X., Javors M.A., Galli A., France C.P., and Daws L.C. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J. Neurochem. 94 (2005) 1402-1410
30. Patterson T.A., Brot M.D., Zavosh A., Schenk J.O., Szot P., and Figlewicz D.P. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68 (1998) 11-20
31. Ranje C., and Ungerstedt U. High correlations between number of dopamine cells, dopamine levels and motor performance. Brain Res. 134 (1977) 83-93
32. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11 (1986) 157-198
33. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479 (2003) 23-40
34. 3H]spiroperidol. Behav. Neurosci. 99 (1985) 831-841
35. Saller C.F. Dopaminergic activity is reduced in STZ-treated rats. Neurosci. Lett. 49 (1984) 301-306
36. Salomon L., Lanteri C., Glowinski J., and Tassin J.P. Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc. Natl. Acad. Sci. USA 103 (2006) 7476-7481
37. Schulingkamp R.J., Pagano T.C., Hung D., and Raffa R.B. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci. Biobehav. Rev. 24 (2000) 855-872
38. Segal D.S., and Mandell A.J. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2 (1974) 249-255
39. Sevak R.J., Koek W., and France C.P. Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy. Eur. J. Pharmacol. 517 (2005) 64-67
40. Sevak R.J., Koek W., Galli A., and France C.P. Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats. J. Pharmacol. Exp. Ther. 320 (2007) 1216-1223
41. Sevak R.J., Owens W.A., Koek W., Galli A., Daws L., and France C.P. Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats. J. Neurochem. 101 (2007) 151-159
42. Shuster L., Yu G., and Bates A. Sensitization to cocaine stimulation in mice. Psychopharmacology 52 (1977) 185-190
43. Stuber G.D., Evans S.B., Higgins M.S., Pu Y., and Figlewicz D.P. Food restriction modulates amphetamine-conditioned place preference and nucleus accumbens dopamine release in the rat. Synapse 46 (2002) 83-90
44. Uhl G.R., Hall F.S., and Sora I. Cocaine, reward, movement and monoamine transporters. Mol. Psychiatry 7 (2002) 21-26
45. Uhl G.R. Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and Parkinsonism. Mov. Disord. 18 (2003) S71-S80
46. Wolfe W.L., and Maisto S.A. The relationship between eating disorders and substance abuse: moving beyond co-prevalence research. Clin. Psychol. Rev. 20 (2000) 617-631